Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008630 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | TBPH | Winningham Rick E | CEO, Dir | A - Grant | $8.64 | +2,704 | 1.56M | +0.2% | +$23.4K | |
| I | 2024-03-19 | 2024-03-15 | TBPH | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | +3,900 | 3,900 | New | $0 |
| M | 2024-03-19 | 2024-03-15 | TBPH | Winningham Rick E | CEO, Dir | G - Gift | $0.00 | -10.9K | 1.55M | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-15 | A | A | 2,704 | $8.64 | 1,561,473 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-03-15 | G | A | 3,900 | $0.00 | 3,900 | I As Custodian | — | — | (F4) The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose. |
| 3 | Common | Ordinary Shares | 2024-03-15 | G | D | 7,000 | $0.00 | 1,554,473 | D | — | — | |
| 4 | Common | Ordinary Shares | 2024-03-15 | G | D | 3,900 | $0.00 | 1,550,573 | D | — | — |